Alexander Zdravkov
Publicado em 05/11/2025 às 14:10
Novo Nordisk Stock: Q3 Miss, Oversold Charts, and Lobbying Questions
Novo Nordisk shares fell sharply after the Danish pharmaceutical giant reported weaker-than-expected third-quarter results, missing Wall Street estimates on both revenue and earnings per share.
The c... [4510 symbols]